These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9620203

  • 1. Immune response to recombinant visna virus Gag and Env precursor proteins synthesized in insect cells.
    Rafnar B, Tobin GJ, Nagashima K, Gonda MA, Gunnarsson E, Andrésson OS, Georgsson G, Torsteinsdóttir S.
    Virus Res; 1998 Feb; 53(2):107-20. PubMed ID: 9620203
    [Abstract] [Full Text] [Related]

  • 2. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
    Luo L, Li Y, Cannon PM, Kim S, Kang CY.
    Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10527-31. PubMed ID: 1438241
    [Abstract] [Full Text] [Related]

  • 3. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 01; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mucosal immunization against ovine lentivirus using PEI-DNA complexes and modified vaccinia Ankara encoding the gag and/or env genes.
    Reina R, Barbezange C, Niesalla H, de Andrés X, Arnarson H, Biescas E, Mazzei M, Fraisier C, McNeilly TN, Liu C, Perez M, Carrozza ML, Bandecchi P, Solano C, Crespo H, Glaria I, Huard C, Shaw DJ, de Blas I, de Andrés D, Tolari F, Rosati S, Suzan-Monti M, Andrésdottir V, Torsteinsdottir S, Petursson G, Lujan L, Pepin M, Amorena B, Blacklaws B, Harkiss GD.
    Vaccine; 2008 Aug 18; 26(35):4494-505. PubMed ID: 18606204
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The restricted IgG1 antibody response to maedi visna virus is seen following infection but not following immunization with recombinant gag protein.
    Bird P, Reyburn HT, Blacklaws BA, Allen D, Nettleton P, Yirrell DL, Watt N, Sargan D, McConnell I.
    Clin Exp Immunol; 1995 Nov 18; 102(2):274-80. PubMed ID: 7586678
    [Abstract] [Full Text] [Related]

  • 9. Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection.
    González B, Reina R, García I, Andrés S, Glaria I, Alzueta M, Mora MI, Jugo BM, Arrieta-Aguirre I, de la Lastra JM, Rodríguez D, Rodríguez JR, Esteban M, Grilló MJ, Blacklaws BA, Harkiss GD, Chebloune Y, Luján L, de Andrés D, Amorena B.
    Vaccine; 2005 Jul 29; 23(34):4342-52. PubMed ID: 16005743
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins.
    Anderson MJ, Porter DC, Moldoveanu Z, Fletcher TM, McPherson S, Morrow CD.
    AIDS Res Hum Retroviruses; 1997 Jan 01; 13(1):53-62. PubMed ID: 8989427
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors.
    Fraisier C, Arnarson H, Barbezange C, Andrésdŏttir V, Carrozza ML, De Andrés D, Tolari F, Rosati S, Luján L, Pépin M, Amorena B, Harkiss G, Blacklaws B, Suzan-Monti M.
    J Virol Methods; 2007 Dec 01; 146(1-2):363-7. PubMed ID: 17675253
    [Abstract] [Full Text] [Related]

  • 13. Assembly and immunogenicity of chimeric Gag-Env proteins derived from the human immunodeficiency virus type 1.
    Truong C, Brand D, Mallet F, Roingeard P, Brunet S, Barin F.
    AIDS Res Hum Retroviruses; 1996 Mar 01; 12(4):291-301. PubMed ID: 8906989
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes.
    Niesalla H, de Andrés X, Barbezange C, Fraisier C, Reina R, Arnarson H, Biescas E, Mazzei M, McNeilly TN, Liu C, Watkins C, Perez M, Carrozza ML, Bandecchi P, Solano C, Crespo H, Glaria I, Huard C, Shaw DJ, de Blas I, de Andrés D, Tolari F, Rosati S, Suzan-Monti M, Andrésdottir V, Torsteinsdottir S, Petursson G, Badiola J, Lujan L, Pepin M, Amorena B, Blacklaws B, Harkiss GD.
    Vaccine; 2009 Jan 07; 27(2):260-9. PubMed ID: 18984025
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and assembly of chimeric human immunodeficiency virus gag pseudovirions.
    Tobin GJ, Li GH, Williamson JC, Nagashima K, Gonda MA.
    Intervirology; 1996 Jan 07; 39(1-2):40-8. PubMed ID: 8957668
    [Abstract] [Full Text] [Related]

  • 17. Budding and secretion of HIV Gag-Env virus-like particles from recombinant human adenovirus infected cells.
    Luo L, Li Y, Yong Kang C.
    Virus Res; 2003 Mar 07; 92(1):75-82. PubMed ID: 12606078
    [Abstract] [Full Text] [Related]

  • 18. Development of transgenic sheep that express the visna virus envelope gene.
    Clements JE, Wall RJ, Narayan O, Hauer D, Schoborg R, Sheffer D, Powell A, Carruth LM, Zink MC, Rexroad CE.
    Virology; 1994 May 01; 200(2):370-80. PubMed ID: 8178428
    [Abstract] [Full Text] [Related]

  • 19. Detection of Maedi-Visna virus antibodies using a single fusion transmembrane-core p25 recombinant protein ELISA and a modified receiver-operating characteristic analysis to determine cut-off values.
    Boshoff CH, Dungu B, Williams R, Vorster J, Conradie JD, Verwoerd DW, York DF.
    J Virol Methods; 1997 Jan 01; 63(1-2):47-56. PubMed ID: 9015275
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.